Growth arrest and non-apoptotic cell death associated with the suppression of c-myc Expression in MCF-7 breast tumor cells following acute exposure to doxorubicin-Reference-Cited by-同舟云学术

Growth arrest and non-apoptotic cell death associated with the suppression of c-myc Expression in MCF-7 breast tumor cells following acute exposure to doxorubicin

Published:1996-04 Issue:7 Volume:51 Page:931-940
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Fornari Frank A.,Jarvis W.David,Grant Steven,Orr Michael S.,Randolph Joyce K.,White Frances K.H.,Gewirtz David A.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference62 articles.

1. Cancer of the breast: The past decade;Henderson;N Engl J Med,1980

2. Interference with DNA unwinding by doxorubicin in MCF-7 breast tumor cells;Fornari;Mol Pharmacol,1994

3. Pharmacokinetics of adriamycin in patients with breast cancer: Correlation between pharmacokinetic parameters and clinical short-term response;Robert;Eur J Cancer Clin Oncol,1982

4. Improved high-performance liquid chromatography assay of doxorubicin: Detection of circulating aglycones in human plasma and comparison with thin-layer chromatography;Brenner;Cancer Chemother Pharmacol,1985

5. Induction of differentiation and non-apoptotic cell death associated with nascent DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells exposed to a therapeutically relevant concentration of doxorubicin;Fornari;Cell Growth Differ,1994

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of tRNA-derived small RNAs in MAPK signaling pathway: implications for cancer and beyond;Frontiers in Genetics;2024-03-26

2. The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells;Pharmaceutics;2023-03-30

3. The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer;Frontiers in Oncology;2023-01-18

4. TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas;Clinical Cancer Research;2021-08-25

5. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies;Journal of Hematology & Oncology;2021-08-09